Activation of histamine H3 receptors inhibits carrier-mediated norepinephrine release in a human mode of protracted myocardial ischemia

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 494-500

  Hatta, Eiichiro ^b   Yasuda, Keishu ^a,b   Levi, Roberto ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITINE; CLOBENPROPIT; DESIPRAMINE; HISTAMINE H3 RECEPTOR; NORADRENALIN; TETRODOTOXIN; THIOPERAMIDE; CARRIER PROTEIN; SODIUM; SODIUM PROTON EXCHANGE PROTEIN;

ARTICLE; CONTROLLED STUDY; HEART ATRIUM; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; ION TRANSPORT; NORADRENALIN RELEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; SYMPATHETIC INNERVATION; AGED; ANOXIA; FEMALE; HISTAMINE RELEASE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

AGED; ANOXIA; CARRIER PROTEINS; DESIPRAMINE; FEMALE; HISTAMINE RELEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; RECEPTORS, HISTAMINE H3; SODIUM; SODIUM-HYDROGEN ANTIPORTER;

EID: 0030612275     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ARRANG, J. M., GARBARG, M., LANCELOT, J. C., LECOMTE, J. M., POLLARD, H., ROBBA, M., SCHUNACK, W. AND SCHWAHTZ, J. C.: Highly potent and selective ligands for histamine H3-receptors. Nature 327: 117-123, 1987.
2. 3 receptor antagonist. Eur. J. Pharmacol. 250: 147-152, 1993.
3. BEAVEN, M. A. AND SHAFF, R. E.: New inhibitors of histamine-N-methyltrans-ferase. Biochem. Pharmacol. 28: 183-188, 1979.
4. BENEDICT, C. R., SHELTON, B., JOHNSTONE, D. E., FRANCIS, G., GREENBERG, B., KONSTAM, M., PROBSTFIELD, J. L. AND YUSUF, S.: Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 94: 690-697, 1996.
5. BRAUNWALD, E. AND SOBEL, B. E.: Coronary blood flow and myocardial ischemia. In Heart Disease: A Textbook of Cardiovascular Medicine, ed. by E. Braunwald, pp. 1191-1221, W. B. Saunders, Philadelphia, 1988.
6. 3 receptor negatively coupled to phosphoinositide turnover in the human gastric cell line HGT1. J. Biol. Chem. 267: 25315-25320, 1992.
7. DART, A. M. AND Du, X.-J.: Unexpected drug effects on autonomic function during myocardial ischaemia. Cardiovasc. Res. 27: 906-914, 1993.
8. + + channels. J. Pharmacol. Exp. Ther. 269: 221-229, 1994.
9. FORMAN, M. B., OATES, J. A., ROBERTSON, D., ROBEKTSON, R. M., ROBERTS, L. J., 2D AND VIRMANI, R.: Increased adventitial mast cells in a patient with coronary spasm. N. Engl. J. Med. 313: 1138-1141, 1985.
10. 3 receptor agonist. J. Pharmacol. Exp. Ther. 263: 304-310, 1992.
11. GREENGARD, P.: Neuronal phosphoproteins: Mediators of signal transduction. Mol. Neurobiol. 1: 81-119, 1987.
12. HILL, S. J., GANELLIN, C. R., TIMMERMAN, H., SCHWARTZ, J. C., SHANKLEY, N. P., YOUNG, J., M., SCHUNACK, W., LEVI, R. AND HAAS, H. L.: International Union of Pharmacology. XIII. Classification of Histamine Receptors. Pharmacol. Rev. 49: 253-278, 1997.
13. HILLE, B.: Ionic Channels of Excitable Membranes, pp. 1-607, Sinauer Associates Inc., Sunderland, MA, 1992.
14. 3 receptors in myocardial ischemia: Their role as regulators of exocytotic norepinephrine release. J. Pharmacol. Exp. Ther. 271: 1259-1266, 1994.
15. 3-receptors in the human heart. Circ. Res. 77: 206-210, 1995.
16. 2-adrenoceptors. Circ. Res. 78: 475-481, 1996.
17. IMAMURA, M. AND LEVI, R.: Bradykinin promotes exocytotic and carrier-mediated norepinephrine release in myocardial ischemia-reperfusion (Abstract). Circulation 92: suppl I, I-568, 1995.
18. Ju, Y. K., SAINT, D. A. AND GAGE, P. W.: Hypoxia increases persistent sodium current in rat ventricular myocytes. J. Physiol. (Lond.) 497: 337-347, 1996.
19. KALSNER, S. AND RICHARDS, R.: Coronary arteries of cardiac patients are hyper-reactive and contain stores of amines: A mechanism for coronary spasm. Science 223: 1435-1437, 1984.
20. + exchanger isoforms (NHE-1, -2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways. J. Biol. Chem. 270: 29209-29216, 1995.
21. 3 receptor model. Naunyn-Schmiedeberg's Arch. Pharmacol. 348: 498-503, 1993.
22. KURZ, T., RICHARDT, G., HAGL, S., SEYFARTH, M. AND SCHÖMIG, A.: Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J. Mol. Cell. Cardiol. 27: 1161-1172, 1995.
23. KÜBLER, W. AND STRASSER, R. H.: Signal transduction in myocardial ischaemia. Eur. Heart J. 15: 437-445, 1994.
24. LEVI, R., RUBIN, L. E. AND GROSS, S. S.: Histamine in cardiovascular function and dysfunction: recent developments. In Handbook of Experimental Pharmacology, Vol. 97: Histamine and Histamine Antagonists. ed. by B. Uvnas, pp. 347-383, Springer-Verlag, Berlin/Heidelberg, 1991.
25. LEVITAN, I. B.: Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu. Rev. Physiol. 56: 193-212, 1994.
26. + exchange inhibitor, on intracellular pH regulation in the guinea-pig ventricular myocyte. Br. J. Pharmacol. 118: 1905-1912, 1996.
27. MOE, O. W., AMEMIYA, M. AND YAMAJI, Y.: Activation of protein kinase A acutely inhibits and phosphorylates Na/H exchanger NHE-3. J. Clin. Invest. 96: 2187-2194, 1995.
28. MÜNCH, G., KURZ, T., URLBAUER, T., SEYFARTH, M. AND RICHARDT, G.: Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia. Br. J. Pharmacol. 118: 1855-1861, 1996.
29. NUMANN, R., HAUSCHKA, S. D., CATTERALL, W. A. AND SCHEUER, T.: Modulation of skeletal muscle sodium channels in a satellite cell line by protein kinase C. J. Neurosci. 14: 4226-4236, 1994.
30. +-exchange inhibitor Hoe 642 an intracellular pH, calcium and sodium in isolated rat ventricular myocytes. Pflugers Arch. 433: 26-34, 1996.
31. SCHOLZ, W., ALBUS, U., COUNILLON, L., GOGELEIN, H., LANG, H. J., LINZ, W., WEICHERT, A. AND SCHÖLKENS, B. A.: Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res. 29: 260-268, 1995.
32. SCHÖMIG, A.: Catecholamines in myocardial ischemia: Systemic and cardiac release. Circulation 82: 13-22, 1990.
33. 3 receptors in a canine model of pacing-induced heart failure: A cause of increased norepinephrine release (Abstract)? Circulation 94: suppl I, 1-406, 1996.
34. + exchanger (NHE3): Resistance to amiloride and inhibition by protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 90: 9110-9114, 1993.
35. + exchange system in various cell types. Biochem. Biophys. Res. Commun. 116: 86-90, 1983.
36. + exchangers. Physiol. Rev. 77: 51-74, 1997.
37. WOLFF, A. A. AND LEVI, R.: Histamine and cardiac arrhythmias. Circ. Res. 58: 1-16, 1986.
38. WOLFF, A. A. AND LEVI, R.: Ventricular arrhythmias parallel cardiac histamine efflux after coronary artery occlusion in the dog. Agents Actions 25:296-306 1988.